The NLRP3 inflammasome has emerged as a critical mediator of the steatosis-to-NASH transition through its influence on ubiquitous pro-inflammatory and pro-fibrogenic determinants. The gene discussed is NLRP3; the disease is metabolic dysfunction-associated steatohepatitis.